Name: DiD-Labeled LP-01 LNP-EGFP mRNA
SKU: LDLY-0325-LD576
Rating: 5 (1 reviews)

Transfersome Development: Edge Activators, Size Optimization, and Permeation Testing
High-Ethanol Ethosomes: Drug Loading, Stability, and Skin Irritation in Transdermal Delivery
Dermal Delivery: Franz Diffusion Cells vs. Dialysis
Liposomes Fail in Skin Applications: A Practical Troubleshooting Guide
Key CQAs for Liposomal Skin Delivery: Stability, Loading and Irritation
Gradient Loading and Formulation Design for Small Molecule Liposomes
Protein & Peptide Liposomes: Preventing Denaturation and Controlled Release
Liposome vs. LNP: The Key Difference in Nucleic Acid Delivery
Nucleic Acid Liposomal Delivery: Endosomal Escape and Expression
Prodrug Liposomes: Translating Chemical Design into Delivery Advantages
Enzyme-Loaded Liposomes: Activity Retention, Protection & Batch Consistency
Adjuvant Liposome Composition Shapes the Immune Activation Window & Safety Profile
Multivesicular Liposomes: High Payload Capacity for Sustained Drug Release
Encapsulation vs. Delivery: Payload Compatibility in Liposomal Formulations
Liposome Payload Troubleshooting: Low Encapsulation, Precipitation & Uncontrolled Release
Optimizing LNP Molar Ratios for Transfection Efficiency
Scalability Challenges in mRNA-LNP Manufacturing
Beyond mRNA: LNP Delivery for CRISPR/Cas9
Cationic Lipids Evolution: DOTAP to Ionizable Lipids
LNP Storage Stability: Lyophilization vs. Liquid
Modulating LNP Biodistribution: Overcoming Liver Accumulation
Active vs. Passive Targeting (EPR): A Guide to Tumor Drug Delivery
Immunoliposomes: Comparing Pre-insertion vs. Post-insertion Techniques
Crossing the BBB: Advances in Transferrin and Peptide-Modified Liposomes
pH-Responsive Liposomes for Tumor Microenvironment
Thermosensitive Liposomes combined with HIFU
Aptamer-Modified Liposomes: A Cost-Effective Antibody Alternative
Ethosomes vs Transfersomes for Dermal Delivery
Strategies for Encapsulating Poorly Water-Soluble Small Molecules in Liposomes
Multivesicular Liposomes: The Architecture of Sustained Release
Mechanisms of Liposomal Adjuvants in Enhancing Vaccine Immune Response
Protecting Enzymatic Activity: Liposomal Encapsulation Strategies for Enzymes
Cryo-TEM vs. DLS: Interpreting Discrepancies in Liposome Particle Size Data
Validating In Vitro Release Methods: Dialysis vs. Sample Separation Techniques
Predicting Long-Term Stability of Liposomal Suspensions using Zeta Potential
Troubleshooting Low Liposome Encapsulation Efficiency
Application of Multi-omics Analysis in Liposome Toxicology Assessment
The Ultimate Guide to Liposome Preparation
Fluorescent Liposomes for Cellular Uptake: Labeling, Controls, and Troubleshooting
How to Design Stealth Liposomes for Long Circulation
Homemade vs. Commercial Kits: Why Standardization Matters in Liposome Research
Develop Targeted Liposomes: Target Selection to Cellular Validation
Optimizing Ligand Density on Liposomes for Targeted Delivery
Directional Antibody Conjugation and Activity Retention in Immunoliposome Development
Peptide-Modified Liposomes: Screening and Conjugation Strategies
High-Affinity Aptamers and Efficient Liposomal Delivery
When to Use Cleavable PEG in Lipid-Based Delivery
Glycosylated Liposomes: Balancing Receptor-Mediated Uptake and Immune Recognition
Folic Acid and Other Vitamin Ligands for Targeted Liposomes
Formulation Optimization to Targeting: Liposome Parameters and Biological Readouts
Imaging Liposome Development: Labeling Strategy, Signal-to-Noise Ratio, and Stability
Charged Liposome Development: Cationic vs Neutral vs Anionic
Cationic Liposome Development for Efficient Transfection with Reduced Toxicity
Neutral Liposome Development for Stability and Long Circulation
Anionic Liposomes in Drug Delivery: Surface Charge and Cellular Uptake
PG Anionic Liposome: Membrane Stability and Payload Compatibility
PG Anionic Liposomes for Membrane Stability and Drug Compatibility
Stimuli-Responsive Liposomes: Design, Mechanisms, and Applications
pH-Responsive Liposomes: Materials, Triggers, and Release Kinetics
Long-Circulating pH-Responsive Liposomes for Triggered Delivery
Dual Validation Strategies for ROS-Responsive Liposome Development
ATP-Responsive Liposomes: Trigger Selectivity and Leakage Control
Light-Responsive Liposomes: Materials and Controlled Release Profiles
Ultrasound-Responsive Liposomes: Trigger Thresholds and Release Validation
Magnetic Liposomes: Particle Size and Stability Control
Formulation Strategies Beyond PEGylation for Long Circulating Liposome Development
Polysaccharide-Coated Liposomes for Stability, Adhesion, and Release
Biomimetic Nanoparticle Development vs. Conventional Liposomes for Delivery Strategy
Optimizing Fluorescent Liposomes for Signals, Leakage, and Imaging
Functional Liposome Validation for Uptake, Localization, Release, and Stability
Choosing the Right Liposome Characterization Service for Formulation
Lipid Ratio, Cholesterol, and PEG-Lipid Composition in Liposome Performance
In Vitro Release Kinetics for Mechanism and PK Evaluation in Liposome Development
Liposome Stability Evaluation Guide for Storage and Stress Testing
Liposome Formulation Safety Evaluation: From Hemolysis to Residual Solvent Testing

DiD-Labeled LP-01 LNP-EGFP mRNA (CAT#: LDLY-0325-LD576)

Description

This product is a DiD-labeled LNP prepared with ionizable lipid (LP-01), helper lipid, cholesterol and PEGylated lipid, encapsulating EGFP mRNA. EGFP mRNA, a common fluorescence reporter, translates into enhanced green fluorescent protein, which exhibits an excitation wavelength of 488 nm and emission at 507 nm. It is only for research purposes.

Ionizable/Cationic Lipid

LP-01

Fluorescent Dye

DiD

Excitation/Emission

644/665 nm

Cargo

EGFP mRNA

Modification

Unmodified

Application

Reporter gene

Storage

Store at -80°C. Avoid freeze-thaw cycles.

Size

55 μl, 110 μl

Download

DataSheet

MSDS

For Research Use Only. Not For Clinical Use

Online Inquiry